Endonovo Therapeutics Inc
OTC:ENDV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Endonovo Therapeutics Inc
OTC:ENDV
|
US |
|
Lum Chang Creations Ltd
SGX:LCC
|
SG |
|
Fevertree Drinks PLC
F:FV8
|
UK |
|
B&S Group SA
F:70B
|
LU |
|
C
|
Captor Capital Corp
SWB:NMVA
|
CA |
Shareholder Yield
Current shareholder yield for ENDV is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ENDV Price
Endonovo Therapeutics Inc
| Average Annual Return | -45.25% |
| Standard Deviation of Annual Returns | 36.21% |
| Max Drawdown | -100% |
| Market Capitalization | 180.8k USD |
| Shares Outstanding | 1 807 560 000 |
| Percentage of Shares Shorted |
N/A
|
ENDV Return Decomposition
Main factors of price return
Stock Splits
ENDV's latest stock split occurred on Dec 20, 2019
The company executed a 1-for-1000 stock split, meaning that for every 1000 shares held, investors received 1 new share.
Before the split, ENDV traded at 0.0013 per share. Afterward, the share price was about 1.49.
The adjusted shares began trading on Dec 20, 2019. This was stock split number 2 in ENDV's history, following the previous one in May 15, 2014.
